CN112250660A
|
|
Preparation method of salbutamol sulfate impurity
|
CN111978188A
|
|
Preparation method of mexiletine hydrochloride impurity C
|
CN110818817A
|
|
Sugammadex sodium diphenyl phosphine oxide derivative impurity and preparation method thereof
|
CN110105469A
|
|
The easypro more glucose sodium impurity and preparation method thereof of one kind
|
CN108675943A
|
|
The preparation method of one planting sand library Ba Qu key intermediates
|
CN107641074A
|
|
The production method of mexiletine hydrochloride
|
CN106588771A
|
|
Besifloxacin hydrochloride key intermediate preparation method
|
CN105334275A
|
|
Detection method for sildenafil citrate related substances
|
CN105566260A
|
|
Furosemide preparation method
|
CN104926763A
|
|
Synthetic preparation method for key intermediate of ramelteon
|
CN104788395A
|
|
Synthesis preparation method of linezolid key intermediate
|
CN104788443A
|
|
Synthesis preparation method of rivaroxaban key intermediate
|
CN104764825A
|
|
Method for separating and detecting enantiomer of ezetimibe key intermediate
|
CN103130709A
|
|
3-aminopropionic acid piperidine amide compound with HIV activity, synthetic method and application
|
CN103076423A
|
|
Separation and detection method for besifloxacin enantiomer
|
CN102140095A
|
|
Green new process for preparing tizanidine hydrochloride
|
CN101245064A
|
|
Process for producing hydrochloric berberine
|
CN101244994A
|
|
Novel method for producing 2,4,5-trifluoro benzene acetic acid
|